BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33127330)

  • 1. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
    Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
    Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
    Arsoy D; Giori NJ; Woolson ST
    Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Johnson SA; Jones AE; Young E; Jennings C; Simon K; Fleming RP; Witt DM
    Thromb Res; 2021 Oct; 206():120-127. PubMed ID: 34455129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man.
    Matharu GS; Garriga C; Whitehouse MR; Rangan A; Judge A
    J Arthroplasty; 2020 Sep; 35(9):2631-2639.e6. PubMed ID: 32532481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Apixaban Safe and Effective for Venous Thromboembolism Prophylaxis After Primary Total Hip and Total Knee Arthroplasties?
    Rooney T; Barrack RL; Clohisy JC; Nunley RM; Lawrie CM
    J Arthroplasty; 2021 Jul; 36(7S):S328-S331. PubMed ID: 33888386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
    Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
    Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty.
    Deng W; Huo L; Yuan Q; Huang D; Li Q; Tian W
    BMC Musculoskelet Disord; 2021 Jul; 22(1):608. PubMed ID: 34229632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis.
    Zhang J; Chen Z; Zheng J; Breusch SJ; Tian J
    Arch Orthop Trauma Surg; 2015 Jun; 135(6):759-72. PubMed ID: 25854654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of symptomatic in-hospital VTEs in Asian patients undergoing joint arthroplasty was low: a prospective, multicenter, 17,660-patient-enrolled cohort study.
    Zeng Y; Si H; Wu Y; Yang J; Zhou Z; Kang P; Pei F; Shen B
    Knee Surg Sports Traumatol Arthrosc; 2019 Apr; 27(4):1075-1082. PubMed ID: 30386998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
    Singh G; Prentice HA; Winston BA; Kroger EW
    J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous Thromboembolism despite Ongoing Prophylaxis after Fast-Track Hip and Knee Arthroplasty: A Prospective Multicenter Study of 34,397 Procedures.
    Petersen PB; Jørgensen CC; Kehlet H;
    Thromb Haemost; 2019 Nov; 119(11):1877-1885. PubMed ID: 31587249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?
    Warren JA; Sundaram K; Anis HK; Kamath AF; Higuera CA; Piuzzi NS
    J Arthroplasty; 2020 Jan; 35(1):259-264. PubMed ID: 31530463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.
    Migita K; Bito S; Nakamura M; Miyata S; Saito M; Kakizaki H; Nakayama Y; Matsusita T; Furuichi I; Sasazaki Y; Tanaka T; Yoshida M; Kaneko H; Abe I; Mine T; Ihara K; Kuratsu S; Saisho K; Miyahara H; Segata T; Nakagawa Y; Kamei M; Torigoshi T; Motokawa S
    Arthritis Res Ther; 2014 Jul; 16(4):R154. PubMed ID: 25047862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
    ; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
    JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.